Nektar News | Artistopia.com



< < < < < > > > > > More Info on Nektar Similar Undetermined Music Search Artistopia

Headlines

Nektar rises as analyst evaluates pipeline
BusinessWeek
Nektar Therapeutics shares rose Wednesday after a Jefferies & Co. analyst started covering the stock with a "Buy" rating, pointing to its promising drug pipeline. THE SPARK: Analyst Biren Amin said he expects Nektar's share price to rise over the next ...
Roth Capital Initiates Coverage on Nektar Therapeutics (NKTR)Movie News Guide (blog)

all 3 news articles »

Jefferies Starts Nektar Therapeutics (NKTR) at Buy
StreetInsider.com (subscription)
Jefferies initiates coverage on Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and $9.50 price target. The firm comments, "Nektar has built a pegylation delivery platform that is the engine of its drug development efforts.

and more »

Jefferies Group Analysts Begin Coverage on Nektar Therapeutics (NKTR)
Daily Political
Equities research analysts at Jefferies Group (NYSE: JEF) started coverage on shares of Nektar Therapeutics (NASDAQ: NKTR) in a research note issued to investors on Wednesday. The firm set a “buy” rating on the stock. Shares of Nektar Therapeutics ...

Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
MarketWatch (press release)
SAN FRANCISCO, May 2, 2012 /PRNewswire via COMTEX/ -- Nektar Therapeutics (NASDAQ:NKTR) today reported its financial results for the first quarter ended March 31, 2012. Cash, cash equivalents, and investments at March 31, 2012 were $498.8 million as ...
Nektar Therapeutics Beats Up on Analysts Yet AgainDailyFinance
Nektar Therapeutics Loss Widens, Misses Estimate - Quick FactsNASDAQ

all 9 news articles »

Biotechnology Stocks To Watch Ahead Of ASCO 2012: Part 2
Seeking Alpha
Nektar Therapeutics (NKTR): Nektar Therapeutics, a clinical-stage biopharmaceutical company, engages in developing a pipeline of drug candidates that utilize its PEGylation and polymer conjugate technology platforms. Nektar has a robust R&D pipeline of ...

and more »

RUMBLINGS: For Charter One, what's in a name?
Crain's Detroit Business
Last summer, B. Nektar Meadery in Ferndale increased its production by 500 percent, but it is still having a hard time keeping up with demand for its Zombie Killer, a carbonated mead made from Michigan apple cider, tart cherries and wildflower honey.

and more »

Backyard Barbecue
Morning Star
Several meaderies, such as B. Nektar and Acoustic will also be on hand, as well as the Northern Natural Cidery and Winery. “The cool thing is not only do you get to sample so many great beers, but you also can talk to the brewers,” Lawson said.

and more »

The Week in Beer: Celebrating Mom and microbrews
AnnArbor.com
If so, you may be interested in the free — oh yeah, I dropped the f-bomb — tasting of B. Nektar meads at the Wine Seller, 2721 Plymouth Rd, from 5-8 pm And you have to give B. Nektar some credit: They've recently released an “IPA mead,” hoping that ...

and more »

Fitch Affirms RPI Finance Trust's Ratings at 'BBB-'
MarketWatch (press release)
In February, RPI FT also completed the purchase of royalty-bearing interests in UCB's Cimzia, and Roche's Mircera for $124 million from Nektar Therapeutics. Fitch sees the company maintaining a weighted average useful life of the diversified asset ...

and more »

New Stock Coverage: Facebook Finally Finds a Friend
Minyanville.com
Biotechs: Dendreon (DNDN) is initiated with an Underperform at Jefferies, which has a new Buy on Nektar Therapeutics (NKTR). Cerner (CERN): Lazard launches Buy rated research on the healthcare IT stock. Coca-Cola Enterprises (CCE): Société Générale has ...

and more »

Undetermined Music Artists

Nektar In The News

Headlines